Introduction
Inherited predisposition and resistance to lung tumorigenesis in mice is under polygenic control (Manenti et al., 2000; Dragani, 2003) . The SWR/J strain is a high susceptible strain and carries susceptibility alleles at the pulmonary adenoma-susceptibility 1 (Pas1), -resistance 2 and 4 (Par2 and Par4) loci (Manenti et al., 1997a) . The Par4 locus, mapped in the centromeric region of Chromosome 6, in a cross between the SWR/J and the intermediate susceptible BALB/c strain (Manenti and Dragani, 2004) , shows a sharp and narrow Lod score peak (Manenti et al., 1997a) , suggesting that the locus activity may be determined by a variation in a single gene. The mapping of the Par4 locus has not been confirmed in two other genetic linkage studies involving the BALB/c strain (Par4 resistance allele) crossed with the A/J strain, highly susceptible to lung tumorigenesis (Obata et al., 1996; Festing et al., 1998) . Since a locus cannot exert allele-specific effects in a cross originating from two strains carrying the same allele, the available data suggest that Par4 locus activity is mediated by a polymorphism between the BALB/c and the SWR/J strain, and that A/J mice presumably carry the same allele as BALB/c mice at this locus.
Identification of a Par4 candidate gene(s) would provide insight into a genetic mechanism of inherited predisposition to lung tumorigenesis in mice and might serve in testing the gene for a possible role in human lung cancer. In the present study, we performed candidate gene analysis for Par4 locus activity by analysing mRNA expression levels and germline polymorphisms in seven genes mapping in the Par4 interval. Since recent findings suggest the involvement of some lung tumor modifier loci in the genetic control of skin carcinogenesis (Saran et al., 2002) and of the acute inflammatory response (Maria et al., 2003) , we also tested candidate Par4 gene polymorphisms in genetic models of outbred mice phenotypically selected for resistance (Car-R) and susceptibility (Car-S) to skin carcinogenesis (Saran et al., 2000) , or selected for high (AIRmax) and low (AIRmin) acute inflammatory response (Biozzi et al., 1998) . Both lines originated from the same F0 population generated from eight inbred strains (Biozzi et al., 1998; Saran et al., 2000) .
A functional amino-acid variation in the juxtamembrane domain of the Met proto-oncogene-encoded protein was identified for candidacy of the Par4 locus; the same amino-acid variation and additional variations in the same juxtamembrane domain of the MET gene occurred, although rarely, in the germline of human lung adenocarcinoma patients.
Results

Identification of Met as a Par4 candidate gene
In the (BALB/c Â SWR/J)F2 intercross, we located the peak Lod score of the Par4 locus between genetic markers D6Mit50 (3.3 cM, MGD; 17.2 Mb, Ensembl) and D6Mit116 (5.5 cM MGD; 25.1 Mb, Ensembl) (Manenti et al., 1997a) , that is, in a region of 2.2 cM in genetic length, containing 22 known genes and 27 putative genes (http://www.ensembl.org/Mus_musculus/).
We began the analysis of Par4 candidate genes by testing 1-Mb interval in the proximal region of the Par4 interval, where seven genes map: Tes (testin), Cav2 (caveolin-2), Cav1 (caveolin-1), Met (Met proto-oncogene tyrosine kinase), Capza2 (capping protein alpha 2), St7 (suppression of tumorigenicity 7), and Wnt2 (wingless-related MMTV integration site 2) (Figure 1 ).
Semiquantitative RT-PCR assay in normal adult lung showed a clear PCR product for all candidate genes (not shown). However, transcript levels of all candidate genes, as well as types and levels of Cav1 and St7 mRNA isoforms, were similar in the normal lungs of BALB/c and SWR/J strains (not shown), making identification of gene candidacy based on differential expression levels unlikely.
In BALB/c and SWR/J strains, the nucleotide sequences of the full-length coding regions of the candidate genes were analysed for polymorphisms that might be related to the functional Par4 locus activity. Alignment of BALB/c versus SWR/J sequences of Tes, Cav1, Cav2, Capza2, St7, and Wnt2 genes revealed no polymorphisms.
Comparison of the 20 exons of the Met gene (based on the Ensembl genomic DNA sequence and mRNA of Acc. # NM_008591) in BALB/c and SWR/J mice revealed silent variations in exon 8 (A2244G; Acc. # AY558815, AY558818) and exon 9 (T2301C, T2346C, A2358G; Acc. # AY558816, AY558819), and a C2902T coding SNP in exon 13 (Acc. # AY558817, AY558820) that caused a Arg968Cys amino-acid change as compared to the wild-type Met protein sequence (NP_032617) (Figure 2 The role of Arg968Cys Met gene variation in lung tumorigenesis was tested in a backcross population of SWR/J Â (SWR/J Â Car-R) mice treated with urethane followed by TPA for a combined skin and lung tumorigenesis study (Saran et al., 2002) . A Lod score of 28.8 was observed between the Met variation and lung tumor multiplicity (Table 1) , with 45% of the phenotypic variance explained, indicating that the Met gene variation plays an important role in determining lung cancer susceptibility in this backcross population.
Met gene candidacy for the Par4 locus was further tested in one intercross and in five backcross populations of mice treated with urethane and analysed for lung tumor response. Since both parental strains of these populations carry the same Met Arg allele and mice cannot be genotyped for the Met polymorphism, we genotyped the D6Mit204 and D6Mit50 microsatellite markers that map closely to the Met gene. No significant association between the microsatellite markers and lung tumor multiplicity was observed in any of these six genetic linkage populations, one of which included BALB/c in the parental strains (BALB/c Â C3H/HeJ F2 intercross) (Table 1) . Thus, the Par4 locus is not detectable when both parental strains carry the same Met allele. Sequence analysis of the entire Met exon 13 in the mouse strains listed in Table 1 or progenitor of Car-R, Car-S, AIRmax, or AIRmin lines, showed no additional nucleotide variations.
The Met variation in skin tumor and inflammatory phenotypes
Microsatellite analysis of the Par4 locus in 40 Car-R and Car-S chromosomes indicated a borderline (Àlog PE 3-4) LD in 10 of 19 microsatellites mapping from 2.31 to 19 Mb (Ensembl); however, no defined peak LD region indicative of a conserved haplotype was observed (not shown), suggesting that the borderline LD may reflect either random allele segregation during phenotypic selection of the lines or a locus with a weak effect. The variant Cys968 allele was absent in 20 Car-R chromosomes, whereas it was present in four of 20 Car-S chromosomes, but the difference between Car-R and Car-S mice was not statistically significant. In the backcross population of SWR/J Â (SWR/J Â Car-R) mice treated with urethane/TPA (Saran et al., 2002) , the Met gene Arg968Cys variation showed no significant linkage with skin papilloma multiplicity at the end of TPA promotion or with skin tumor multiplicity at the end of the experiment (not shown), consistent with the LD results in Car-R and Car-S mice. Analysis of 15 microsatellites mapping from 2.31 to 27.19 Mb (Ensembl), in 40 AIRmax and AIRmin chromosomes, revealed no statistically significant LD, indicating that the Par4 region is not involved in the genetic control of inflammatory response. Accordingly, analysis of 48 chromosomes from AIRmax and AIRmin mice showed that all mice of both lines carry the Arg allele at homozygosity (not shown).
Basal phosphoprotein levels in normal lungs
To examine the effects of the Arg968Cys Met variation on baseline tyrosine phosphorylation of cellular proteins in the normal lung, immunoblot analysis was carried out to detect possible differences between the SWR/J (968Cys allele) and BALB/c (wild-type 968Arg allele) strains in tyrosine phosphorylation. As expected, positive control GTL16 cells showed high levels of MET tyrosine phosphorylation (Figure 3 , top panel), but no strong differences in the constitutive tyrosine phosphorylation pattern of lung cellular proteins were observed between the mouse strains ( Figure 3 with the antiphosphotyrosine antibody showed no strain differences (not shown). The paxillin protein, either native or phosphorylated (Y31), was detectable in the lungs of both strains, without apparent strain differences (not shown).
MET gene variations in human germline and lung adenocarcinomas
Nucleotide sequence analysis of 141 bp of the MET gene whole exon 14 in 40 ADCA patients revealed no germline variations. Analysis of codons 988, 1009, and 1010 in 126 pairs of germline and lung ADCA DNAs identified the Arg988Cys variation at heterozygosity in one patient (clinical stage III disease) and the Thr1010Ile at heterozygosity in one patient (clinical stage III disease) ( Table 2 ). The Pro1009Ser variation, previously Table 2 ). No somatic mutations at these codons were detected in lung ADCA samples as compared to the corresponding germline DNAs (not shown).
Discussion
We began the positional cloning of Par4 candidate genes by analysis of mRNA expression levels and nucleotide polymorphisms of genes mapping in a 1-Mb subregion of the Par4 locus containing seven candidate genes. We chose this approach instead of classical preliminary restriction of the mapping region using congenic mice, since the Par4 mapping interval was already of manageable size (2.2 cM, containing 22 known genes) and since congenic mice might not ensure significant restriction of the region. Indeed, several studies aimed at shortening QTL intervals by producing congenic lines failed to narrow such intervals to a size o2 cM (Zhang et al., 2000; Shultz et al., 2003) . No differences were detected in mRNA expression levels of any candidate genes in normal lungs of BALB/c versus SWR/J mice. Consistent with those findings, our recent survey of gene expression in normal lung of 18 mouse inbred strains (including SWR/J and BALB/c) for an association with lung tumor susceptibility did not point to any differentially expressed gene mapping in the Par4 region (Gariboldi et al., 2003) . Since mRNA expression levels of the candidate Par4 genes examined did not differ in the BALB/c and SWR/J strains, gene coding region polymorphisms would likely be functionally related to the Par4 locus activity, that is, the modulation of genetic susceptibility to lung tumorigenesis.
Our data point to an Arg968Cys coding variation in the Met gene as the best candidate for the Par4 locus. Arg is a positive-charged, polar amino acid, whereas Cys is a small hydrophobic amino acid: the Arg968Cys variation is therefore a nonconservative change. Among 79 inbred mouse strains, only the SWR/J and its subline carried the 968Cys allele. The Met candidacy for the Par4 locus is further supported by the detection of the Par4 locus in two genetic crosses polymorphic for the Met gene, but not in 11 other independent crosses whose both parental strains carry the same Arg allele of the Met gene (Table 1) . Among these genetic crosses, five backcrosses examined herein carry lung cancer modifier loci yet to be mapped , but not the Par4 locus.
Additional, indirect support to the Met gene candidacy for the Par4 locus derived from genotyping Car-R and Car-S mice (a model of skin tumorigenesis resistance/susceptibility) (Saran et al., 2002) and AIRmax and AIRmin mice (a model of acute inflammatory response susceptibility/resistance) (Maria et al., 2003) using polymorphic microsatellite markers and Met gene variation. No significant associations between Par4 locus and either skin tumor susceptibility or acute inflammatory response were detected. Accordingly, the Met gene variation was absent or rare in these models.
The Arg968Cys variation in the Met gene is located in mouse exon 13, which corresponds to human exon 14. This exon encodes the juxtamembrane domain of the receptor that exerts a negative regulatory function on MET signaling (Gandino et al., 1994; Weidner et al., 1995; Peschard et al., 2001) . The amino acids of the MET juxtamembrane domain were highly conserved during evolution, as they showed 100% identity in mammals (Homo sapiens, Pan troglodytes, Bos taurus, Canis familiaris, Felis catus, Mus musculus, Rattus norvegicus) and 89 and 68% identity in the evolutionary distant Gallus gallus and Takifugu rubripes, respectively (not shown), supporting the hypothesis that this protein domain plays an important role in MET biochemical activity. The homologous Arg968 amino acid was conserved in mammals and changed to Trp in the Fugu and Danio rerio fishes (http://www.ncbi.nlm.nih.gov/ BLAST/, not shown).
Of note is a recent report of the same Met 968Cys allele, herein described, occurring at the human homologous amino acid (i.e. 988Cys), in two human small-cell lung cancer (SCLC) cell lines (Ma et al., 2003) and considered by the authors as a somatic mutation. However, we did not observe somatic mutations in the MET juxtamembrane domain in tumor samples of lung ADCA patients.
Out of 126 patients, we observed the MET Arg988Cys variation in the germline of an ADCA patient, as well as (Table 2) . Herein, we have not carried out a population-based association study to test the lung cancer risk associated with the MET gene rare variations, because a study including about 3000 cases and 3000 controls would be required to detect, with a 80% power (two-sided test; a ¼ 0.05), an OR of 2.0 for the variant (Cys) allele if present at a frequency of 0.008 (i.e. E1/126) in the general population.
However, although the rare variations of the MET gene juxtamembrane domain may have a low impact in the risk of lung cancer at general population level, we cannot exclude that these variations may affect lung cancer risk in carriers. Indeed, species comparisons showed that the Met Arg/Cys variation is rare also in the population of mouse inbred strains but, when present in a genetic cross, it strongly affects the lung tumorigenesis phenotype.
The human 988Cys allele displayed functional enhancement of in vitro tumorigenicity in transfected human SCLC cells (Ma et al., 2003) , thus supporting the candidacy of the mouse Met Arg968Cys variation as the functional variation responsible for the Par4 locus activity. Normal lungs of BALB/c and SWR/J strains did not show apparent differences in the baseline tyrosine phosphorylation of proteins that could be associated to different biochemical activity of the Met alleles. Also, the paxillin protein phosphorylation levels, reported to be associated with Met protein activation (Ma et al., 2003) , were similar in both strains. However, these results do not rule out possible differences in specific proteins that cannot be detected by analysis of whole-protein lysates or Met protein immunoprecipitation, or differences occurring in certain physiological or pathological conditions. Our finding that the same amino-acid variation occurs as a germline variation associated with cancer susceptibility in mice and as a germline variation in humans supports the usefulness of mouse models of genetic predisposition/resistance to cancer for analysis of the corresponding human cancers. Our results also point to the involvement of Met gene in lung carcinogenesis, making this gene a potential target for new cancer therapies (Longati et al., 2001 ).
Materials and methods
Mouse strains and genetic cross
129/SvJ, A/J, BALB/c, C3H/HeJ, C57L/J, CBA/J, LP/J, ST/J, and SWR/J mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA); Car-R and Car-S mice (generations N15-N16), and AIRmax and AIRmin mice (generations N29-N30) were maintained as described (Biozzi et al., 1998; Saran et al., 2000) .
A backcross population of 231 male and female SWR/J Â (SWR/J Â Car-R) mice was treated intraperitoneally (i.p.) with urethane (Sigma, St Louis, MO, USA) dissolved in water at a dose of 1000 mg/kg body weight (tumor initiation). After 7 days, mice were treated topically with 1.0 mg 12-O-tetradecanoylphorbol-13-acetate (TPA) (twice per week) for 14 weeks (tumor promotion). Time of appearance (latency), number, and incidence of papillomas were recorded at each promoting treatment and at the end of the experiment (30 weeks after tumor initiation). Five backcross populations of 103-135 A/J Â F1 mice obtained by crossing female A/J mice with male ST/J, LP/J, C57L/J, 129/SvJ, and CBA/J mice were treated i.p. at a dose of 1000 mg/kg body weight with urethane (Sigma) dissolved in water. The previously described intercross population of (BALB/cJ Â C3H/HeJ)F2 mice (179 males and 193 females), treated with urethane and analysed for lung tumor multiplicity (Manenti et al., 1997b) , was also used for genetic linkage analysis in the Par4 region.
In all experiments, tumors on the lung surface were counted after tissue fixation in 10% buffered formalin. Histopathologic analysis of selected lesions was performed in hematoxylin and eosin-stained sections.
Paired human tissue samples
Lung adenocarcinoma (ADCA) surgical specimens were obtained from 126 pathologically documented patients enrolled at Istituto Nazionale Tumori, Milan, for whom clinical data were available; the corresponding normal lung tissue was obtained at surgery (De Gregorio et al., 1998) or peripheral blood samples were used as the control tissue.
DNAs
Mouse genomic DNAs were either extracted from frozen spleen or tail with the Genomix Kit (Talent, Trieste, Italy), or purchased (a panel of 79 DNAs from inbred mouse strains) from The Jackson Laboratory. Human DNAs were extracted from a small surgical specimen of lung adenocarcinoma or nontumor lung parenchyma, or from peripheral blood samples, using the Genomix Kit (Talent).
Nucleotide sequence analysis of candidate genes PCR primers were purchased from MWG-Biotech AG (Ebersberg, Germany) and PCR was carried out using a GeneAmp PCR System 9700 (Applied Biosystems, Foster City, CA, USA). For detection of polymorphisms, the coding regions of the candidate genes were PCR-amplified from BALB/c and SWR/J lung cDNA or genomic DNA. PCR primers amplifying fragments 300-500 bp in length were designed on the corresponding Ensembl and GenBank sequences. PCR products were subcloned into the pCR s 2.1-TOPO s vector (Invitrogen, Carlsbad, CA, USA) or directly purified using the QIAquick PCR Purification Kit or the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, USA) for subsequent sequencing. Exon 13 of mouse Met gene was PCR amplified and directly sequenced from 129/SvJ, A/J, C3H/HeJ, C57BL/6J, C57L/J, CBA/J, DBA/2J, LP/J, P/J, SJL/J, SPRET/Ei, and ST/bJ genomic DNA. A preliminary search for polymorphisms in exon 14 of the human MET gene was carried out on germline DNA from 40 ADCA patients using intronic PCR primers flanking the exon, and then by direct sequencing of the PCR products. Codons 988, 1009 and 1010 were also sequenced in the group of 126 human lung ADCA paired DNAs to search for new variants, using pyrosequencing. Nucleotide sequences of the amplified fragments were obtained using an ABI PRISM 377 automatic sequencer or a 3100 Genetic Analyzer (Applied Biosystems), and aligned and compared using Genomatix Dialign software (http://www.genomatix.de).
Genotyping
The D6Mit204 and D6Mit50 genetic markers were PCRamplified using MIT primers and 32 P-labeling, and analysed by acrylamide gel electrophoresis. Mouse and human MET gene single-nucleotide polymorphisms (SNPs) were automatically genotyped by pyrosequencing on a PSQ96 system (Pyrosequencing AB, Uppsala, Sweden). Briefly, a short fragment containing the SNP was PCR-amplified using biotinylated (mouse: GGACTTACACTTCGGGCACT; human: CAGATTC ATTTGAAACCATTTCTGT) and unmodified (mouse: TCTCTGTTTTAAGATCTGGGCAGT; human: TGTTTT AAGATCTGGGCAGTGA) PCR primers. The PCR reaction mix contained 50 ng of genomic DNA, 100 mM dNTPs, 1.5 mM MgCl 2 , 0.5 U of AmpliTaq Gold Polymerase (Perkin Elmer/ Roche), and 5 pmol of each primer in a final volume of 27 ml. PCR was carried out at 951C for 15 s, 55-611C for 10 s and 721C for 20 s in a GeneAmp PCR System 9700 (Applied Biosystems) for a total of 40 cycles. Pyrosequencing was performed according to the manufacturer's instructions using sequencing primers (mouse: TGGGCAGTGAATTAGTT; human: TGGGCAGTGAATTAGTT, GCCCGAAGTG TAAGC).
Semiquantitative RT-PCR
Total RNA was isolated from normal lung tissue of adult male BALB/c and SWR/J mice using the RNeasy s Midi Kit (Qiagen) and reverse-transcribed using oligo(dT) 20 primers and the ThermoScriptTM RT-PCR System (Invitrogen). cDNA was synthesized using 4 mg of total RNA. PCR primers were designed on the GenBank mRNA sequences of the candidate genes, and used to amplify gene-specific fragments from the cDNAs. cDNA amounts from the two mouse strains were first normalized by comparing, in serial dilutions, the amounts of PCR product of the housekeeping glyceraldehyde-3-phosphate dehydrogenase gene (Gapd). For each candidate gene, PCRs using gene-specific primers (sequences available upon request) were performed on serial dilutions of the normalized cDNAs. Cycle number ranged from 20 to 35 and was adjusted to use nonsaturating conditions. PCR products were loaded on 2-4% agarose gels, stained with ethidium bromide, photographed, and quantitatively analysed using an image analysis system.
Antibodies and immunoblotting
Normal lungs from adult BALB/c and SWR/J male mice were homogenized in lysis buffer (50 mM Tris-HCl pH 7.4, 5 mM EDTA, 150 mM NaCl, 0.5% NP-40) containing 50 ml/ml protease inhibitor cocktail 'Complete mini' EDTA-free (Roche Diagnostic GmbH, Mannheim, Germany), 1 mM sodium orthovanadate and 1 mM NaF. GTL16 human cells derived from a gastric carcinoma overexpressing MET protein (positive control) were lysed in the same buffer. After addition of Laemmli buffer to equal amounts (100 mg) of the lung lysates and to 3.5 mg of the cell lysate, proteins were resolved by 8% SDS-PAGE and transferred onto Hybond-C super nitrocellulose membranes (Amersham Biosciences, Little Chalfont Buckinghamshire, UK). Membranes were incubated with antiphosphotyrosine monoclonal antibody 4G10 (Upstate Biotechnology, Inc., Lake Placid, NY, USA) (1 mg/ml, 1 : 5000 dilution), anti-mouse monoclonal c-Met p140 antibody B-2 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) (0.2 mg/ml, 1 : 500 dilution), antipaxillin phospho Y31 antibody ab4832 (Abcam, Cambridge, UK) (1 : 1000 dilution), or antipaxillin monoclonal antibody 5H11 (Upstate) (1 : 1000 dilution) in blocking solution (1% bovine serum albumin, 3% ovalbumin in TBS-T: 25 mM Tris-HCl pH ¼ 7.2, 150 mM NaCl, 0.1% Tween 20), and then incubated with secondary antibody. For reprobing, protein stripping was carried out at 601C for 30 min in 62.5 mM Tris-HCl pH 6.7, 2% SDS and 20 mM b-mercaptoethanol. Whole-protein lysates (6 mg) from normal lungs of SWR/J and BALB/c mice were pretreated with protein G (Sigma), immunoprecipitated with the c-Met p140 antibody B-2, resolved by SDS-PAGE gel, followed by Western blot analysis with antiphosphotyrosine monoclonal antibody 4G10, and detected as indicated above. Proteins were detected using ECL Western blotting detection reagents (Amersham Biosciences).
Statistical analysis
The linkage between lung tumor multiplicity and Met gene polymorphism was analysed by MAPMAKER/QTL (Lincoln et al., 1992) . Linkage disequilibrium (LD) for segregation of marker alleles in Car-R and Car-S lines and in AIRmax and AIRmin lines was evaluated by the Fisher's exact test, using SAS software (SAS/STAT User's Guide, Version 8, Cary, NC, USA). P-values were transformed to the negative logarithm of P (Àlog P) to provide a more accessible presentation of the results. LD was considered significant at Àlog P>3 (Po0.001).
